Research into safe distance for battery energy storage systems One new development in the energy sector is the temporary storage of renewable energy. For example, energy can be stored in a community battery.
No changes to chromium (VI) adverse health effect list No changes will be made to the list of adverse health effects that may be caused by exposure to chromium (VI) in the workplace. According to RIVM, the latest scientific literature has resulted in no new insights.
Night shift workers more likely to have poor work-life balance People who work at night are more than 2.5 times more likely to have a poor work-life balance. They find it more difficult to combine their jobs and private lives than people who only work in daytime. This is one of the results of a study by RIVM and TNO.
RIVM and TNO describe impact of future developments on occupational health and safety RIVM and the Netherlands Organisation for Applied Scientific Research (TNO) have investigated the potential impact of developments in the next 20 years on occupational health and safety. How will artificial intelligence affect safety at work? iStock
Safe working practices: RIVM creates a list of 1,400 substances without a European occupational exposure limit for health purposes Employees sometimes come into contact with hazardous substances at work. RIVM has compiled a list of 1,400 hazardous substances for which the European Commission has not yet set an occupational exposure limit.
NS did not adequately protect employees from exposure to chromium (VI) Employees of Dutch Railways (NS) may have been exposed to chromium (VI) between 1970 and 2020. Although it is not known exactly how often or how much this occurred, it is reasonable to assume that NS employees who were exposed to chromium (VI) may develop certain medical conditions.
Reducing greenhouse gas emissions via procurement partnerships By optimising collaboration when purchasing products and services, the government can reduce greenhouse gas emissions. This was the conclusion of a study by the National Institute for Public Health and Environmental Protection (RIVM) into so-called 'buyer groups'.
RIVM formulates criteria for R&D of sustainable pharmaceuticals As part of an international research project, RIVM has formulated criteria for R&D of sustainable new pharmaceuticals. These GREENER criteria are an important first step to develop pharmaceuticals that do not impact the environment..
New WHO protocol for integrated One Health surveillance of antibiotic resistance: the Tricycle protocol The World Health Organization (WHO) has developed a protocol for global One Health surveillance of antimicrobial resistance based on one indicator, Extended Spectrum Beta-Lactamase producing E. WHO
Towards a sustainable, healthy future for everyone: EU project INHERIT offers policy solutions Today, on 10 December a policy toolkit will be presented at the final conference of the European four-year research project INHERIT.